Overview

A Post-marketing Research on Jinyebaidu Granule in Treating Patients With Acute Upper Respiratory Infection

Status:
Unknown status
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
Study topic:A comparative effectiveness research on Jinyebaidu granule in treating patients with acute upper respiratory infection: A double blind, double dummy, randomized, controlled trial. It is a post-marketing clinical study to evaluate effectiveness, safety and cost-effectiveness on Jinyebaidu granule in treating acute upper respiratory infection. Objectives of Study:This study aims to evaluate effectiveness, safety and cost-effectiveness on Jinyebaidu granule in treating patients with acute upper respiratory infection. Study design:multi-center double-blind, double-dummy, randomized, controlled trial
Phase:
Phase 4
Details
Lead Sponsor:
China Academy of Chinese Medical Sciences
Collaborators:
Beijing Hospital of Traditional Chinese Medicine
Changchun University of Chinese Medicine
First Affiliated Hospital of Heilongjiang Chinese Medicine University
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Guangdong Provincial Hospital of Traditional Chinese Medicine
Liaoning University of Traditional Chinese Medicine
Shandong University of Traditional Chinese Medicine